![]() |
市場調查報告書
商品編碼
1946058
全球動物膳食和治療營養市場:預測(至2034年)-按產品、動物種類、原料類型、分銷管道、應用和地區分類的分析Veterinary Diet & Therapeutic Nutrition Market Forecasts to 2034 - Global Analysis By Product, Animal Type, Ingredient Type, Distribution Channel, Application and By Geography |
||||||
根據 Stratistics MRC 的研究,預計到 2026 年,全球動物飲食和治療營養市場將達到 51.9 億美元,在預測期內以 7.6% 的複合年成長率成長,到 2034 年將達到 93.3 億美元。
動物性飲食和治療營養是指以科學配方研製的專用動物營養產品,旨在支持伴侶動物和家畜特定健康問題的預防、管理和治療。這些膳食以獸醫學和營養學為基礎,針對肥胖、腎臟病、胃腸道疾病、糖尿病、過敏和關節疾病等問題進行研發。治療營養通常由獸醫推薦或處方,透過針對性營養素、控制成分和功能性添加劑,改善健康狀況、提高生活品質並支持長期疾病管理,從而輔助臨床治療。
寵物慢性病發生率呈上升趨勢
伴侶動物慢性病發生率的不斷上升是推動動物飼料和治療營養市場發展的主要動力。隨著寵物老化和久坐生活方式的盛行,肥胖、糖尿病、腎功能障礙、胃腸道過敏、過敏和關節疾病等病症日益普遍。隨著獸醫學逐漸轉向疾病的預防和長期管理,治療性飲食作為治療的重要組成部分,其應用也日益廣泛。這種對營養干預措施的持續臨床依賴,將繼續推動全球市場成長。
高純度標準與基礎設施成本
高標準的純化要求和基礎設施需求嚴重阻礙了市場擴張。獸用治療性飼料需要嚴格的品管、專業的加工設施和先進的配方技術,以確保安全性、有效性和符合法規要求。這些因素推高了生產和營運成本,最終導致產品價格上漲。因此,在價格敏感的市場中,產品的可負擔性成為一大挑戰,限制了市場滲透率。小規模生產商也面臨准入壁壘,限制了市場競爭,減緩了創新步伐。
寵物人性化和優質化的趨勢
寵物人性化趨勢的加速發展為動物飼料和治療營養市場帶來了強勁的成長機會。寵物飼主越來越將寵物視為家庭成員,並將它們的健康和長壽放在首位,從而推動了對高階、針對特定疾病的營養解決方案的需求。這種轉變促使人們在實證、獸醫推薦的寵物食品上投入更多資金。此外,人們對預防醫學和健康餵食方式的日益重視,也促進了專業治療配方的普及,尤其是在都市區和已開發市場。
嚴格的監管要求
嚴格的法規結構對市場成長構成重大威脅。獸用治療性處方糧必須符合當地監管機構制定的嚴格的安全性、標籤和功效標準。應對這些複雜的法規會導致研發週期延長、核准成本增加,並加重製造商的合規負擔。各國監管要求的差異進一步使全球推廣策略變得複雜。未能滿足不斷變化的標準可能導致產品召回或退出市場,從而造成營運風險並限制創新步伐。
新冠疫情對動物飲食和治療營養市場產生了複雜的影響。雖然供應鏈中斷和物流挑戰暫時影響了生產和分銷,但疫情封鎖期間寵物飼養量的增加支撐了長期需求成長。人們對寵物健康和預防醫學日益成長的關注促使更多人依賴治療營養。此外,電子商務和遠距獸醫諮詢的普及提高了寵物獲取專業營養的途徑,在一定程度上抵消了疫情期間面臨的短期營運挑戰。
在預測期內,小型哺乳動物細分市場預計將佔據最大的市場佔有率。
由於全球範圍內飼養的寵物(如犬貓)數量龐大,預計小型哺乳動物市場在預測期內將佔據最大的市場佔有率。這些動物容易罹患慢性病和老齡化疾病,並且需要長期的營養管理。寵物就診次數的增加、醫療費用支出的成長以及寵物飼主對治療性營養的日益重視,都進一步鞏固了該細分市場的主導地位。針對特定品種和疾病需求的持續產品創新,正在強化該細分市場的市場地位。
預計在預測期內,寵物專賣店細分市場將呈現最高的複合年成長率。
在預測期內,寵物專賣店預計將呈現最高的成長率,這主要得益於其專注於拓展產品系列併提供高階治療產品。這些商店為尋求獸醫推薦營養方案的寵物飼主提供專家建議、精心挑選的產品系列以及更深入的互動體驗。都市化加快、可支配收入增加以及消費者對個人化購物體驗的日益偏好,都進一步推動了這一成長。此外,與線上平台的整合提升了服務的可近性和便利性,加速了該細分市場在全球範圍內的擴張。
在預測期內,北美預計將保持最大的市場佔有率,這主要得益於其較高的寵物擁有率、先進的獸醫基礎設施以及對治療性營養的高度重視。該地區受益於高階寵物食品的早期普及以及透過獸醫診所和專賣店建立的廣泛分銷網路。優惠的報銷政策、成熟的行業巨頭以及持續的產品創新進一步鞏固了市場滲透率,使北美成為全球收入的主要貢獻者。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於寵物擁有量的增加、快速的都市化以及可支配收入的成長。人們對寵物健康意識的提高以及獸醫服務覆蓋範圍的擴大,正在推動對治療性營養食品的需求。此外,西方寵物護理實踐的影響以及有組織的零售和電子商務平台的興起,也促進了市場的加速發展。新興經濟體尚未開發的巨大潛力,也使亞太地區成為一個具有高成長潛力的地區。
According to Stratistics MRC, the Global Veterinary Diet & Therapeutic Nutrition Market is accounted for $5.19 billion in 2026 and is expected to reach $9.33 billion by 2034 growing at a CAGR of 7.6% during the forecast period. Veterinary Diet & Therapeutic Nutrition refers to specialized, scientifically formulated animal nutrition designed to support the prevention, management, and treatment of specific medical conditions in companion and livestock animals. These diets are developed based on veterinary and nutritional science to address disorders such as obesity, renal disease, gastrointestinal issues, diabetes, allergies, and joint conditions. Typically recommended or prescribed by veterinarians, therapeutic nutrition complements clinical treatment by improving health outcomes, enhancing quality of life, and supporting long-term disease management through targeted nutrient composition, controlled ingredients, and functional additives.
Rising Prevalence of Chronic Pet Health Conditions
The increasing incidence of chronic health conditions among companion animals is a major driver of the Veterinary Diet & Therapeutic Nutrition Market. Disorders such as obesity, diabetes, renal dysfunction, gastrointestinal sensitivities, allergies, and joint-related issues are becoming more prevalent due to aging pet populations and sedentary lifestyles. As veterinary care shifts toward preventive and long-term disease management, therapeutic diets are increasingly recommended as an integral component of treatment. This sustained clinical reliance on nutrition-based interventions continues to propel market growth globally.
High purification and infrastructure costs
High purification standards and infrastructure requirements significantly restrain market expansion. Veterinary therapeutic diets demand stringent quality control, specialized processing facilities, and advanced formulation technologies to ensure safety, efficacy, and regulatory compliance. These factors elevate production and operational costs, which are ultimately reflected in higher product prices. As a result, affordability becomes a challenge in price-sensitive markets, limiting widespread adoption. Smaller manufacturers also face barriers to entry, restricting competition and slowing innovation across the market landscape.
Pet Humanization & Premiumization Trend
The accelerating trend of pet humanization presents a strong growth opportunity for the Veterinary Diet & Therapeutic Nutrition Market. Pet owners increasingly regard animals as family members and prioritize their health and longevity, driving demand for premium, condition-specific nutrition solutions. This shift encourages higher spending on veterinarian-recommended diets backed by clinical evidence. Additionally, growing awareness of preventive healthcare and wellness-focused feeding practices supports the adoption of specialized therapeutic formulations, particularly in urban and developed markets.
Stringent Regulatory Requirements
Stringent regulatory frameworks pose a notable threat to market growth. Veterinary therapeutic diets must comply with rigorous safety, labeling, and efficacy standards imposed by regulatory authorities across regions. Navigating these complex regulations increases development timelines, approval costs, and compliance burdens for manufacturers. Variations in regulatory requirements between countries further complicate global expansion strategies. Failure to meet evolving standards can result in product recalls or market withdrawal, creating operational risks and limiting the pace of innovation.
The COVID-19 pandemic had a mixed impact on the Veterinary Diet & Therapeutic Nutrition Market. While supply chain disruptions and logistical challenges temporarily affected production and distribution, increased pet adoption during lockdowns supported long-term demand growth. Heightened focus on pet health and preventive care encouraged greater reliance on therapeutic nutrition. Additionally, the expansion of e-commerce and tele-veterinary consultations improved accessibility to specialized diets, partially offsetting the short-term operational challenges faced during the pandemic period.
The small mammals segment is expected to be the largest during the forecast period
The small mammals segment is expected to account for the largest market share during the forecast period, due to high global population of companion animals such as dogs and cats. These animals are more prone to chronic and age-related conditions that require long-term dietary management. Increased veterinary visits, higher healthcare spending, and greater awareness of therapeutic nutrition among pet owners further support this segment dominance. Continuous product innovation targeting breed- and condition-specific needs strengthens this segment's market position.
The pet specialty stores segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pet specialty stores segment is predicted to witness the highest growth rate, due to their expanding product portfolios and focus on premium and therapeutic offerings. These stores provide specialized guidance, curated selections, and stronger engagement with informed pet owners seeking veterinarian-recommended nutrition. Growing urbanization, rising disposable income and increased preference for personalized purchasing experiences further fuels the growth. Additionally, integration with online platforms enhances accessibility and convenience, accelerating segment expansion globally.
During the forecast period, the North America region is expected to hold the largest market share, due to high pet ownership rates, advanced veterinary healthcare infrastructure, and strong awareness of therapeutic nutrition. The region benefits from early adoption of premium pet food products and widespread availability through veterinary clinics and specialty retailers. Favorable reimbursement structures, established key players, and continuous product innovation further strengthen market penetration, positioning North America as a dominant contributor to global revenue.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rising pet adoption, rapid urbanization, and increasing disposable income. Growing awareness of pet health and expanding access to veterinary services are driving demand for therapeutic nutrition. Additionally, the influence of Western pet care practices and the emergence of organized retail and e-commerce platforms support market acceleration. Untapped potential in emerging economies further positions Asia Pacific as a high-growth region.
Key players in the market
Some of the key players in Veterinary Diet & Therapeutic Nutrition Market include Purina PetCare (Nestle S.A.), Mars Petcare, Hill's Pet Nutrition (Colgate-Palmolive), Blue Buffalo (General Mills), Royal Canin, Diamond Pet Foods, Veterinary Nutrition Group, Wellness Pet, LLC, NutriSource, Wysong, Natural Balance Pet Foods, Farmina Pet Foods, JustFoodForDogs, EmerAid, LLC, and Virbac.
In October 2025, Mars Petcare and Big Idea Ventures have hand-picked three innovative startups for their 2025 Next Generation Pet Food Program, spotlighting sustainable biotech ingredients and circular feed solutions to transform pet nutrition and reduce environmental impact.
In March 2025, Mars, Incorporated has extended its partnership with the Washington Spirit, becoming the team's Official Petcare Partner, with its logo featured on jerseys and signage, community ticket donations, pet-friendly game nights, and collaborative fan and pet experiences.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.